their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
sustainable development. This shift in recognition of society, environment and corporate governance has been driven by the fact that no business could survive the collapse of society and thus, has to extend its
Practice Lead, GMO, said, “We are witnessing a fundamental shift in the way in which investors are integrating material ESG risks and opportunities, such as climate change, and diversity, into their
) June 12, 2018 Subject Increase of Registered Capital, Allocation and Offering of the Newly Issued Ordinary Shares to a Specific Investor (Private Placement), Application for Waiver from the Requirement
Enclosure 1. Capital Increase Form (F 53-4) 2. Information Memorandum concerning the Offering and Allocation of the Newly Issued Shares of Hydrotek Public Company Limited 3. Information Memorandum concerning
Thailand Enclosure 1. Capital Increase Form (F 53-4) 2. Information Memorandum concerning the Offering and Allocation of the Newly Issued Shares of Hydrotek Public Company Limited 3. Information Memorandum
shareholding percentage will change to 58.15 percent in case of registration of the Company’s paid-up capital resulting from the allocation of the newly issued ordinary shares to the existing shareholders pro
and Allocation of Securities to the Specific Investor (Private Placement) To The President The Stock Exchange of Thailand Attachment 1. Information Memorandum regarding the Acquisition of Assets and
and Allocation of Securities to the Specific Investor (Private Placement) (Amendment 2) To The President The Stock Exchange of Thailand Attachment 1. Information Memorandum regarding the Acquisition of